Rapid increase of demand for biotechnology according to prolongation of life has brought remarkable growth of bio industry in every sector.

Our company has been established to be a leading pharmaceutical company in biophotonics field orienting to popularization of early diagnosis of cancer and its treatment method by supplying photosensitizers and medical devices such as Photofrin and Radachlorin to hospitals centered around university hospitals as well as by researching and developing photosensitizers for next generation photodynamic diagnosis and therapy which are a cutting-edge bio-medical field contributing to prolongation of life.

As conventional treatment methods such as surgical operation, chemotherapy, and radiotherapy have extremely limited remedial values and cause serious side effects by damaging normal tissues, a new tumor-specific therapy has been developed which cures only tumor selectively with preserving function of normal tissues. In future, it is expected that the conventional anti-cancer medicines without selective effect on cancer cells will lose its market share gradually and will be replaced with photodynamic therapy, immunotherapy, cell therapy and anti-angiogenetic therapy based on biological mechanism.

Our company oriented to biophotonics will help to overcome cancer with early diagnosis of cancer by using 5-ALA and a fluorescent endoscope (Photodynamic-Therapy: PDT) and contribute greatly to cancer treatment, relief of symptoms of terminal cancer and maintaining function of important internal organs by spreading Photodynamic-Therapy ( PDT) utilizing next generation photosensitizers.

Our research institute expedites to develop cutting-edge biomedicine technologies which can contribute to making national bio-industry strong as well as health and happiness of human being under the company's slogan " Do not stop until having complete insight into essence".